examined GLP-1 receptor agonist use and risk of MALOs [64]
In SURMOUNT-OSA 1, participants receiving tirzepatide 15 mg experienced mean AHI reductions of 27.4 events per hour from baseline, compared to 4.8 events per hour with placebo
Ceriello A, Esposito K, Testa R, Bonfigli AR, Marra M, Giugliano D
Peptide Sequencing of GLP-1 Peptide is the process of determining the exact amino acid sequence and identifying structural modifications using advanced techniques such as LC-MS/MS
Nanocarrier uptake in midbrain organoids Control or PD organoids were embedded in 10 l Geltrex (Thermo Fischer Scientific) at the bottom of 24-well plates (1 organoid/well), then culture inserts were placed above them containing the BBB model as described in our previous study [24]
It is important to note that dosages may vary depending on the specific research objectives, patient population, and safety considerations